SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reviva Pharmaceuticals Holdings, Inc. – RVPH
NEW YORK, May 16, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. (“Reviva” or the “Company”) (NASDAQ: RVPH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-5
ZIMLog Unveils Transformed Structure and Expanded Scope Pioneering the Future of Logistics with reliable and Personalized Precision
HAIFA, Israel, May 16, 2024 /PRNewswire/ — ZIMLog, a global freight forwarding brand, proudly unveils its renewed structure, reflecting a blend of experience and innovation aimed at meeting the diverse and evolving needs of businesses worldwide. After more than 22 years of successful activity
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. – SAGE
NEW YORK, May 16, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Primerica, Inc. – PRI
NEW YORK, May 16, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Primerica, Inc. (“Primerica” or the “Company”) (NYSE: PRI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 79
Foundry 415 Innovation Group Launches Startup BoostCamp: A Workshop Series to Accelerate Startup Growth and Success
SAN FRANCISCO, May 16, 2024 /PRNewswire/ — Foundry 415 Innovation Group has unveiled its new Startup BoostCamp workshop series designed to empower startups with the knowledge and strategies they need to overcome the most common challenges to scaling and achieving success in the US market. Fou
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Deutsche Bank Aktiengesellschaft – DB
NEW YORK, May 16, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Deutsche Bank Aktiengesellschaft (“Deutsche Bank” or the “Company”) (NYSE: DB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-58
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. – SUPN
NEW YORK, May 16, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”) (NASDAQ: SUPN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against UnitedHealth Group Inc. – UNH
NEW YORK, May 16, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against UnitedHealth Group Inc. (“UnitedHealth” or the “Company”) (NYSE: UNH). Such investors are advised to contact Danielle Peyton at [email protected] or 64
Full-Life Technologies Announces Appointment of Mark S. de Jong, PhD, as Chief Technical Officer
GEMBLOUX, Belgium, May 16, 2024 /PRNewswire/ — Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43
